Is Siegfried Malta Limited FDA approved?

Siegfried Malta Limited holds no registered establishment of its own; 7 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Siegfried Malta Limited make?

7 products are listed under Siegfried Malta Limited in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Siegfried Malta Limited

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 7
Live patents: 0
Countries: 0

Catalogue

Drug listings by form and route

7 active NDC listings: 7 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 7.

Dosage form	NDCs
tablet, film coated	7

Route	NDCs

Labeller name on the listing	NDCs
siegfried malta limited	7

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	Solriamfetol	tablet, film coated	44639-002DRUG FOR FURTHER PROCESSING
-	Solriamfetol	tablet, film coated	44639-003DRUG FOR FURTHER PROCESSING
-	Solriamfetol	tablet, film coated	44639-004DRUG FOR FURTHER PROCESSING
-	Tiagabine HCl	tablet, film coated	44639-005DRUG FOR FURTHER PROCESSING
-	Tiagabine HCl	tablet, film coated	44639-006DRUG FOR FURTHER PROCESSING
-	Tiagabine HCl	tablet, film coated	44639-007DRUG FOR FURTHER PROCESSING
-	Tiagabine HCl	tablet, film coated	44639-008DRUG FOR FURTHER PROCESSING

Enquiry

Common questions

Is Siegfried Malta Limited FDA approved?: Siegfried Malta Limited holds no registered establishment of its own; 7 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Siegfried Malta Limited make?: 7 products are listed under Siegfried Malta Limited in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.